GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.59
-0.32 (-0.46%)
At close: Aug 6, 2026, 4:00 PM EDT
68.13
-1.46 (-2.10%)
Pre-market: Aug 7, 2026, 8:04 AM EDT

GeneDx Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
454.43427.54305.45202.57234.69212.2
Revenue Growth
25.42%39.97%50.79%-13.69%10.60%18.33%
Gross Profit
315.24298.17194.490.01-26.75-16.6
Operating Income
-20.71-13.08-23.21-180.6-667.65-446.15
Net Income
-17.74-21.02-52.29-175.77-548.98-245.39
Earnings Per Share
-3.64-0.73-1.94-7.23-53.63-74.91
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fabric Genomics and Legacy Sema4
31.344.45----
Gene Dx
-423.09302.29194.38122.23-
Legacy Sema4
--3.168.19112.46212.2
Total
454.43427.54305.45202.57234.69212.2

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
132.55171.28141.19130.15123.93427.08
Total Debt
167.4108.63116.17119.2772.3811
Net Cash (Debt)
-34.8562.6625.0210.8851.55416.08
Net Cash Growth
-150.45%130.04%-78.90%-87.61%541.33%
Net Cash Per Share
-1.182.190.930.455.04127.04

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-48.7133.28-28.5-180.15-319.16-190.43
Capital Expenditures
-27.09-19.02-5.49-5.25-7.16-9.4
Free Cash Flow
-75.814.26-33.99-185.4-326.31-199.83
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.37%69.74%63.64%44.43%-11.40%-7.82%
Operating Margin
-4.56%-3.06%-7.60%-89.15%-284.48%-210.25%
Pretax Margin
-23.39%-4.94%-17.23%-87.23%-254.81%-115.64%
Profit Margin
-3.90%-4.92%-17.12%-86.77%-233.91%-115.64%
FCF Margin
-16.68%3.34%-11.13%-91.52%-139.04%-94.17%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
100.14250.14190.96---
P/FCF Ratio
-266.70----
PS Ratio
4.578.907.050.350.445.10